{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:26:43Z","timestamp":1793176003793,"version":"4.5.0"},"reference-count":197,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["AG056673"],"award-info":[{"award-number":["AG056673"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARF-17-505009"],"award-info":[{"award-number":["AARF-17-505009"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Neuroscience Research Institute and Chronic Brain Injury Pilot Award"},{"DOI":"10.13039\/100011500","name":"Research Institute, Nationwide Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH1910309"],"award-info":[{"award-number":["W81XWH1910309"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s12015-020-10068-9","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T12:02:45Z","timestamp":1605182565000},"page":"696-717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"18","author":[{"given":"Lalitha","family":"Venkataraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer R.","family":"Fair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"McElroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Hester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5346-7075","authenticated-orcid":false,"given":"Hongjun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"issue":"10","key":"10068_CR1","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/s41593-018-0236-8","volume":"21","author":"TM Dawson","year":"2018","unstructured":"Dawson, T. M., Golde, T. E., & Lagier-Tourenne, C. (2018). Animal models of neurodegenerative diseases. Nat Neurosci., 21(10), 1370\u20131379. https:\/\/doi.org\/10.1038\/s41593-018-0236-8.","journal-title":"Nat Neurosci."},{"key":"10068_CR2","doi-asserted-by":"publisher","unstructured":"Erkkinen, M. G., Kim, M.-O., & Geschwind, M. D. (2018). Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. Cold Spring Harbor Perspectives in Biology, 10(4). https:\/\/doi.org\/10.1101\/cshperspect.a033118.","DOI":"10.1101\/cshperspect.a033118"},{"issue":"10","key":"10068_CR3","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41593-018-0237-7.Converging","volume":"21","author":"L Gan","year":"2018","unstructured":"Gan, L., Cookson, M. R., Petrucelli, L., et al. (2018). Converging pathways in neurodegeneration, from genetics to mechanisms. Nat Neurosci., 21(10), 1300\u20131309. https:\/\/doi.org\/10.1038\/s41593-018-0237-7.Converging.","journal-title":"Nat Neurosci."},{"issue":"10","key":"10068_CR4","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/s41593-018-0221-2","volume":"21","author":"H Fu","year":"2018","unstructured":"Fu, H., Hardy, J., & Duff, K. E. (2018). Selective vulnerability in neurodegenerative diseases. Nat Neurosci., 21(10), 1350\u20131358. https:\/\/doi.org\/10.1038\/s41593-018-0221-2.","journal-title":"Nat Neurosci."},{"issue":"Suppl","key":"10068_CR5","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nm1066","volume":"10","author":"CA Ross","year":"2004","unstructured":"Ross, C. A., & Poirier, M. A. (2004). Protein aggregation and neurodegenerative disease. Nat Med., 10(Suppl), S10\u2013S17. https:\/\/doi.org\/10.1038\/nm1066.","journal-title":"Nat Med."},{"issue":"10","key":"10068_CR6","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","volume":"21","author":"C Soto","year":"2018","unstructured":"Soto, C., & Pritzkow, S. (2018). Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci., 21(10), 1332\u20131340. https:\/\/doi.org\/10.1038\/s41593-018-0235-9.","journal-title":"Nat Neurosci."},{"issue":"10","key":"10068_CR7","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41593-018-0238-6.Propagation","volume":"21","author":"M Jucker","year":"2018","unstructured":"Jucker, M., & Walker, L. C. (2018). Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases. Nat Neurosci., 21(10), 1341\u20131349. https:\/\/doi.org\/10.1038\/s41593-018-0238-6.Propagation.","journal-title":"Nat Neurosci."},{"issue":"1","key":"10068_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13024-018-0258-4","volume":"13","author":"EGZ Centeno","year":"2018","unstructured":"Centeno, E. G. Z., Cimarosti, H., & Bithell, A. (2018). 2D versus 3D human induced pluripotent stem cell-derived cultures for neurodegenerative disease modelling. Mol Neurodegener., 13(1), 27. https:\/\/doi.org\/10.1186\/s13024-018-0258-4.","journal-title":"Mol Neurodegener."},{"issue":"51","key":"10068_CR9","doi-asserted-by":"publisher","first-page":"15672","DOI":"10.1073\/pnas.1520760112","volume":"112","author":"JG Camp","year":"2015","unstructured":"Camp, J. G., Badsha, F., Florio, M., et al. (2015). Human cerebral organoids recapitulate gene expression programs of fetal neocortex development. Proc Natl Acad Sci U S A., 112(51), 15672\u201315677. https:\/\/doi.org\/10.1073\/pnas.1520760112.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"10068_CR10","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1016\/j.celrep.2016.12.001","volume":"17","author":"C Luo","year":"2016","unstructured":"Luo, C., Lancaster, M. A., Castanon, R., Nery, J. R., Knoblich, J. A., & Ecker, J. R. (2016). Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain. Cell Rep., 17(12), 3369\u20133384. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.001.","journal-title":"Cell Rep."},{"issue":"7","key":"10068_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nbt.3906","volume":"35","author":"MA Lancaster","year":"2017","unstructured":"Lancaster, M. A., Corsini, N. S., Wolfinger, S., et al. (2017). Guided self-organization and cortical plate formation in human brain organoids. Nat Biotechnol., 35(7), 659\u2013666. https:\/\/doi.org\/10.1038\/nbt.3906.","journal-title":"Nat Biotechnol."},{"key":"10068_CR12","doi-asserted-by":"publisher","unstructured":"Sivitilli, A. A., Gosio, J. T., Ghoshal, B., et al. (2020). Robust production of uniform human cerebral organoids from pluripotent stem cells. Life Science alliance, 3(5). https:\/\/doi.org\/10.26508\/lsa.202000707.","DOI":"10.26508\/lsa.202000707"},{"issue":"10","key":"10068_CR13","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/nprot.2014.158.Generation","volume":"9","author":"MA Lancaster","year":"2014","unstructured":"Lancaster, M. A., & Knoblich, J. A. (2014). Generation of Cerebral Organoids from Human Pluripotent Stem Cells. Nat Protoc., 9(10), 2329\u20132340. https:\/\/doi.org\/10.1038\/nprot.2014.158.Generation.","journal-title":"Nat Protoc."},{"issue":"7652","key":"10068_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature22047","volume":"545","author":"G Quadrato","year":"2017","unstructured":"Quadrato, G., Nguyen, T., Macosko, E. Z., et al. (2017). Cell diversity and network dynamics in photosensitive human brain organoids. Nature., 545(7652), 48\u201353. https:\/\/doi.org\/10.1038\/nature22047.","journal-title":"Nature."},{"issue":"51","key":"10068_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1073\/pnas.1520760112","volume":"112","author":"JG Camp","year":"2015","unstructured":"Camp, J. G., Badsha, F., Florio, M., Kanton, S., Gerber, T., & Wilsch-br\u00e4uninger, M. (2015). Human cerebral organoids recapitulate gene expression programs of fetal neocortex development. PNAS., 112(51), 1\u20136. https:\/\/doi.org\/10.1073\/pnas.1520760112.","journal-title":"PNAS."},{"key":"10068_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature25032","volume":"553","author":"SP Pasca","year":"2018","unstructured":"Pasca, S. P. (2018). The rise of three-dimensional human brain cultures. Nature., 553, 437\u2013445. https:\/\/doi.org\/10.1038\/nature25032.","journal-title":"Nature."},{"issue":"5","key":"10068_CR17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nn.2807","volume":"14","author":"X Wang","year":"2011","unstructured":"Wang, X., Tsai, J.-W., LaMonica, B., & Kriegstein, A. R. (2011). A new subtype of progenitor cell in the mouse embryonic neocortex. Nat Neurosci., 14(5), 555\u2013561. https:\/\/doi.org\/10.1038\/nn.2807.","journal-title":"Nat Neurosci."},{"key":"10068_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","volume":"501","author":"MA Lancaster","year":"2013","unstructured":"Lancaster, M. A., Renner, M., Martin, C.-A., et al. (2013). Cerebral organoids model human brain development and microcephaly. Nature., 501, 373. https:\/\/doi.org\/10.1038\/nature12517.","journal-title":"Nature."},{"issue":"7772","key":"10068_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41586-019-1506-7","volume":"573","author":"RD Hodge","year":"2019","unstructured":"Hodge, R. D., Bakken, T. E., Miller, J. A., et al. (2019). Conserved cell types with divergent features in human versus mouse cortex. Nature., 573(7772), 61\u201368. https:\/\/doi.org\/10.1038\/s41586-019-1506-7.","journal-title":"Nature."},{"key":"10068_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrn.2017.107","volume":"18","author":"E Di Lullo","year":"2017","unstructured":"Di Lullo, E., & Kriegstein, A. R. (2017). The use of brain organoids to investigate neural development and disease. Nat Rev Neurosci., 18, 573. https:\/\/doi.org\/10.1038\/nrn.2017.107.","journal-title":"Nat Rev Neurosci."},{"issue":"7793","key":"10068_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41586-020-1962-0","volume":"578","author":"A Bhaduri","year":"2020","unstructured":"Bhaduri, A., Andrews, M. G., Mancia Leon, W., et al. (2020). Cell stress in cortical organoids impairs molecular subtype specification. Nature., 578(7793), 142\u2013148. https:\/\/doi.org\/10.1038\/s41586-020-1962-0.","journal-title":"Nature."},{"issue":"6","key":"10068_CR22","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.celrep.2020.01.038","volume":"30","author":"Y Tanaka","year":"2020","unstructured":"Tanaka, Y., Cakir, B., Xiang, Y., Sullivan, G. J., & Park, I.-H. (2020). Synthetic Analyses of Single-Cell Transcriptomes from Multiple Brain Organoids and Fetal Brain. Cell Reports, 30(6), 1682\u20131689.e3. https:\/\/doi.org\/10.1016\/j.celrep.2020.01.038.","journal-title":"Cell Reports"},{"key":"10068_CR23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41586-019-1289-x","volume":"570","author":"S Velasco","year":"2019","unstructured":"Velasco, S., Kedaigle, A. J., Simmons, S. K., et al. (2019). Individual brain organoids reproducibly form cell diversity of the human cerebral cortex. Nature., 570, 523\u2013527. https:\/\/doi.org\/10.1038\/s41586-019-1289-x.","journal-title":"Nature."},{"issue":"5","key":"10068_CR24","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.cell.2016.04.032.Brain","volume":"165","author":"X Qian","year":"2016","unstructured":"Qian, X., Nguyen, H. N., Song, M. M., et al. (2016). Brain Region-specific Organoids using Mini-bioreactors for Modeling ZIKV Exposure. Cell., 165(5), 1238\u20131254. https:\/\/doi.org\/10.1016\/j.cell.2016.04.032.Brain.","journal-title":"Cell."},{"issue":"3","key":"10068_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1002270","volume":"14","author":"H-M Lanoiselee","year":"2017","unstructured":"Lanoiselee, H.-M., Nicolas, G., Wallon, D., et al. (2017). APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases. PloS Med., 14(3), 1\u201316.","journal-title":"PloS Med."},{"key":"10068_CR26","doi-asserted-by":"publisher","unstructured":"Haass, C., Kaether, C., Thinakaran, G., & Sisodia, S. (2012). Trafficking and Proteolytic Processing of APP. Cold Spring Harb Perspect Med., 1\u201325. https:\/\/doi.org\/10.1101\/cshperspect.a006270.","DOI":"10.1101\/cshperspect.a006270"},{"key":"10068_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcdb.2020.01.005","volume":"105","author":"MS Wolfe","year":"2020","unstructured":"Wolfe, M. S. (2020). Unraveling the complexity of \u03b3-secretase. Semin Cell Dev Biol., 105, 3\u201311. https:\/\/doi.org\/10.1016\/j.semcdb.2020.01.005.","journal-title":"Semin Cell Dev Biol."},{"issue":"15","key":"10068_CR28","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1056\/NEJMc1813435","volume":"380","author":"D Henley","year":"2019","unstructured":"Henley, D., Raghavan, N., Sperling, R., Aisen, P., Raman, R., & Romano, G. (2019). Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer\u2019s Disease. N Engl J Med., 380(15), 1483\u20131485. https:\/\/doi.org\/10.1056\/NEJMc1813435.","journal-title":"N Engl J Med."},{"issue":"23","key":"10068_CR29","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1001\/jama.2009.1866","volume":"302","author":"RC Green","year":"2009","unstructured":"Green, R. C., Schneider, L. S., Amato, D. A., et al. (2009). Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA., 302(23), 2557\u20132564. https:\/\/doi.org\/10.1001\/jama.2009.1866.","journal-title":"JAMA."},{"issue":"11","key":"10068_CR30","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1001\/jamaneurol.2015.0607","volume":"72","author":"V Coric","year":"2015","unstructured":"Coric, V., Salloway, S., van Dyck, C. H., et al. (2015). Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial. JAMA Neurol., 72(11), 1324\u20131333. https:\/\/doi.org\/10.1001\/jamaneurol.2015.0607.","journal-title":"JAMA Neurol."},{"issue":"4","key":"10068_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1210951","volume":"369","author":"RS Doody","year":"2013","unstructured":"Doody, R. S., Raman, R., Farlow, M., et al. (2013). A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease. N Engl J Med., 369(4), 341\u2013350. https:\/\/doi.org\/10.1056\/NEJMoa1210951.","journal-title":"N Engl J Med."},{"issue":"15","key":"10068_CR32","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa1812840","volume":"380","author":"MF Egan","year":"2019","unstructured":"Egan, M. F., Kost, J., Voss, T., et al. (2019). Randomized Trial of Verubecestat for Prodromal Alzheimer\u2019s Disease. N Engl J Med., 380(15), 1408\u20131420. https:\/\/doi.org\/10.1056\/NEJMoa1812840.","journal-title":"N Engl J Med."},{"issue":"6","key":"10068_CR33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1021\/cn2000469","volume":"2","author":"CR Hopkins","year":"2011","unstructured":"Hopkins, C. R. (2011). ACS chemical neuroscience molecule spotlight on ELND006: another \u03b3-secretase inhibitor fails in the clinic. ACS Chem Neurosci., 2(6), 279\u2013280. https:\/\/doi.org\/10.1021\/cn2000469.","journal-title":"ACS Chem Neurosci."},{"key":"10068_CR34","doi-asserted-by":"publisher","unstructured":"Vormfelde, S, V., Pezous, N., Lef\u00e8vre, G., et al. A Pooled Analysis of Three Randomized Phase I\/IIa Clinical Trials Confirms Absence of a Clinically Relevant Effect on the QTc Interval by Umibecestat. Clinical and Translational Science. https:\/\/doi.org\/10.1111\/cts.12832","DOI":"10.1111\/cts.12832"},{"issue":"7526","key":"10068_CR35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nature13800","volume":"515","author":"SH Choi","year":"2014","unstructured":"Choi, S. H., Kim, Y. H., Hebisch, M., et al. (2014). A three-dimensional human neural cell culture model of Alzheimer\u2019s disease. Nature., 515(7526), 274\u2013278. https:\/\/doi.org\/10.1038\/nature13800.","journal-title":"Nature."},{"key":"10068_CR36","doi-asserted-by":"publisher","unstructured":"Kim, Y. H., Choi, S. H., Avanzo, C. D., et al. (2015). A 3D human neural cell culture system for modeling Alzheimer\u2019 s disease. Nature Protocols, 10(7). https:\/\/doi.org\/10.1038\/nprot.2015.065.","DOI":"10.1038\/nprot.2015.065"},{"issue":"1377","key":"10068_CR37","first-page":"1","volume":"11","author":"SS Kwak","year":"2020","unstructured":"Kwak, S. S., Washicosky, K. J., Brand, E., et al. (2020). Amyloid-\u03b242\/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer\u2019s disease. Nat Commun., 11(1377), 1\u201314 https:\/\/ghr.nlm.nih.gov\/condition\/alzheimer-disease#.","journal-title":"Nat Commun."},{"issue":"24","key":"10068_CR38","doi-asserted-by":"publisher","first-page":"23009","DOI":"10.1074\/jbc.M414648200","volume":"280","author":"H-K Wong","year":"2005","unstructured":"Wong, H.-K., Sakurai, T., Oyama, F., et al. (2005). beta Subunits of voltage-gated sodium channels are novel substrates of beta-site amyloid precursor protein-cleaving enzyme (BACE1) and gamma-secretase. J Biol Chem., 280(24), 23009\u201323017. https:\/\/doi.org\/10.1074\/jbc.M414648200.","journal-title":"J Biol Chem."},{"issue":"5","key":"10068_CR39","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1073\/pnas.052436599","volume":"99","author":"WP Esler","year":"2002","unstructured":"Esler, W. P., Kimberly, W. T., Ostaszewski, B. L., et al. (2002). Activity-dependent isolation of the presenilin- gamma -secretase complex reveals nicastrin and a gamma substrate. Proc Natl Acad Sci U S A., 99(5), 2720\u20132725. https:\/\/doi.org\/10.1073\/pnas.052436599.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"14","key":"10068_CR40","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1038\/emboj.2013.146","volume":"32","author":"C Cheret","year":"2013","unstructured":"Cheret, C., Willem, M., Fricker, F. R., et al. (2013). Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles. EMBO J., 32(14), 2015\u20132028. https:\/\/doi.org\/10.1038\/emboj.2013.146.","journal-title":"EMBO J."},{"issue":"1","key":"10068_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.devcel.2018.06.005","volume":"46","author":"C Papadimitriou","year":"2018","unstructured":"Papadimitriou, C., Celikkaya, H., Cosacak, M. I., et al. (2018). 3D Culture Method for Alzheimer\u2019s Disease Modeling Reveals Interleukin-4 Rescues A b 42-Induced Loss of Human Neural Stem Cell Plasticity Article 3D Culture Method for Alzheimer \u2019 s Disease Modeling Reveals Interleukin-4 Rescues A b 42-Induced Loss of Hum. Developmental Cell, 46(1), 85\u2013101.e8. https:\/\/doi.org\/10.1016\/j.devcel.2018.06.005.","journal-title":"Developmental Cell"},{"key":"10068_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mabi.202000004","volume":"20","author":"N Rouleau","year":"2020","unstructured":"Rouleau, N., Cantley, W. L., Liaudanskaya, V., et al. (2020). A Long-Living Bioengineered Neural Tissue Platform to Study Neurodegeneration. Macromol Biosci., 20, 1\u20138. https:\/\/doi.org\/10.1002\/mabi.202000004.","journal-title":"Macromol Biosci."},{"key":"10068_CR43","doi-asserted-by":"publisher","unstructured":"Raja, W. K., Mungenast, A. E., Lin, Y., et al. (2016). Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer\u2019s Disease Phenotypes. PLoS One., 1\u201318. https:\/\/doi.org\/10.1371\/journal.pone.0161969.","DOI":"10.1371\/journal.pone.0161969"},{"key":"10068_CR44","doi-asserted-by":"publisher","unstructured":"Yin, J., VanDongen, A, M. Enhanced Neuronal Activity and Asynchronous Calcium Transients Revealed in a 3D Organoid Model of Alzheimer\u2019s Disease. 2020. https:\/\/doi.org\/10.1101\/2020.07.07.192781. bioRxiv preprint","DOI":"10.1101\/2020.07.07.192781"},{"key":"10068_CR45","doi-asserted-by":"publisher","unstructured":"Ali\u0107, I., Goh, P.A., Murray, A.\u00a0et al. (2020). Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain.\u00a0Mol Psychiatry.\u00a0https:\/\/doi.org\/10.1038\/s41380-020-0806-5.","DOI":"10.1038\/s41380-020-0806-5"},{"key":"10068_CR46","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1038\/s41380-018-0229-8","volume":"23","author":"C Gonzalez","year":"2018","unstructured":"Gonzalez, C., Armijo, E., Bravo-alegria, J., Mays, A. B. C. E., & Soto, C. (2018). Modeling amyloid beta and tau pathology in human cerebral organoids. Mol Psychiatry., 23, 2363\u20132374. https:\/\/doi.org\/10.1038\/s41380-018-0229-8.","journal-title":"Mol Psychiatry."},{"issue":"614","key":"10068_CR47","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","volume":"15","author":"IT Lott","year":"2019","unstructured":"Lott, I. T., & Head, E. (2019). Dementia in Down syndrome: unique insights for Alzheimer disease research. Nat Rev Neurol., 15(614), 135\u2013147.","journal-title":"Nat Rev Neurol."},{"key":"10068_CR48","doi-asserted-by":"crossref","unstructured":"Pavoni, S., Jarray, R., Nassor, F., et al. (2018). Small-molecule induction of A\u03b2 -42 peptide production in human cerebral organoids to model Alzheimer\u2019 s disease associated phenotypes. PLoS One., 1\u201315.","DOI":"10.1371\/journal.pone.0209150"},{"key":"10068_CR49","doi-asserted-by":"publisher","unstructured":"Choi, H., Jun, H., Jinhee, K., et al. (2019). Acetylation changes tau interactome to degrade tau in Alzheimer \u2019 s disease animal and organoid models. Aging Cell, (March), 1\u201313. https:\/\/doi.org\/10.1111\/acel.13081.","DOI":"10.1111\/acel.13081"},{"issue":"2","key":"10068_CR50","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3233\/JAD-2012-120727","volume":"33","author":"L Zhang","year":"2013","unstructured":"Zhang, L. (2013). The role of HDAC6 in Alzheimer\u2019s disease. J Alzheimers Dis., 33(2), 283\u2013295. https:\/\/doi.org\/10.3233\/JAD-2012-120727.","journal-title":"J Alzheimers Dis."},{"issue":"February","key":"10068_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2020.00014","volume":"14","author":"F Nassor","year":"2020","unstructured":"Nassor, F., Jarray, R., Biard, D. S. F., et al. (2020). Long Term Gene Expression in Human Induced Pluripotent Stem Cells and Cerebral Organoids to Model a Neurodegenerative Disease. Front Cell Neurosci., 14(February), 1\u20137. https:\/\/doi.org\/10.3389\/fncel.2020.00014.","journal-title":"Front Cell Neurosci."},{"issue":"4","key":"10068_CR52","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3233\/jad-2008-14409","volume":"14","author":"NS Honson","year":"2008","unstructured":"Honson, N. S., & Kuret, J. (2008). Tau aggregation and toxicity in tauopathic neurodegenerative diseases. J Alzheimers Dis., 14(4), 417\u2013422. https:\/\/doi.org\/10.3233\/jad-2008-14409.","journal-title":"J Alzheimers Dis."},{"issue":"1","key":"10068_CR53","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-1326-3-8","volume":"3","author":"F Liu","year":"2008","unstructured":"Liu, F., & Gong, C.-X. (2008). Tau exon 10 alternative splicing and tauopathies. Mol Neurodegener., 3(1), 8. https:\/\/doi.org\/10.1186\/1750-1326-3-8.","journal-title":"Mol Neurodegener."},{"key":"10068_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep34904","volume":"6","author":"K Imamura","year":"2016","unstructured":"Imamura, K., Sahara, N., Kanaan, N. M., et al. (2016). Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons. Sci Rep., 6, 1\u201310. https:\/\/doi.org\/10.1038\/srep34904.","journal-title":"Sci Rep."},{"issue":"8","key":"10068_CR55","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1177\/1087057116638029","volume":"21","author":"X Medda","year":"2016","unstructured":"Medda, X., Mertens, L., Versweyveld, S., et al. (2016). Development of a Scalable, High-Throughput-Compatible Assay to Detect Tau Aggregates Using iPSC-Derived Cortical Neurons Maintained in a Three-Dimensional Culture Format. J Biomol Screen., 21(8), 804\u2013815. https:\/\/doi.org\/10.1177\/1087057116638029.","journal-title":"J Biomol Screen."},{"key":"10068_CR56","doi-asserted-by":"publisher","unstructured":"Silva, M. C., Ferguson, F. M., Cai, Q., et al. (2019). Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models. eLife, 8:e45457, 1\u20138:e45431. https:\/\/doi.org\/10.7554\/eLife.45457.","DOI":"10.7554\/eLife.45457"},{"key":"10068_CR57","doi-asserted-by":"publisher","first-page":"101541","DOI":"10.1016\/j.scr.2019.101541","volume":"40","author":"L Miguel","year":"2019","unstructured":"Miguel, L., Rovelet-Lecrux, A., Feyeux, M., et al. (2019). Detection of all adult Tau isoforms in a 3D culture model of iPSC-derived neurons. Stem Cell Res., 40, 101541. https:\/\/doi.org\/10.1016\/j.scr.2019.101541.","journal-title":"Stem Cell Res."},{"issue":"4","key":"10068_CR58","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.stemcr.2019.08.011","volume":"13","author":"M Nakamura","year":"2019","unstructured":"Nakamura, M., Shiozawa, S., Tsuboi, D., et al. (2019). Pathological Progression Induced by the Frontotemporal Dementia-Associated R406W Tau Mutation in Patient-Derived iPSCs. Stem cell reports., 13(4), 684\u2013699. https:\/\/doi.org\/10.1016\/j.stemcr.2019.08.011.","journal-title":"Stem cell reports."},{"issue":"41","key":"10068_CR59","doi-asserted-by":"publisher","first-page":"9917","DOI":"10.1523\/JNEUROSCI.0621-17.2017","volume":"37","author":"J Seo","year":"2017","unstructured":"Seo, J., Kritskiy, O., Watson, L. A., et al. (2017). Inhibition of p25\/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia. J Neurosci., 37(41), 9917\u20139924. https:\/\/doi.org\/10.1523\/JNEUROSCI.0621-17.2017.","journal-title":"J Neurosci."},{"key":"10068_CR60","doi-asserted-by":"publisher","unstructured":"Lee, M., Kwon, Y.,. T., Li, M., & Peng, J. (2000). Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature, 405(5), 360\u2013364. https:\/\/doi.org\/10.1038\/35012636.","DOI":"10.1038\/35012636"},{"issue":"7","key":"10068_CR61","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1007\/s12035-015-9369-x","volume":"53","author":"S-L Liu","year":"2016","unstructured":"Liu, S.-L., Wang, C., Jiang, T., Tan, L., Xing, A., & Yu, J.-T. (2016). The Role of Cdk5 in Alzheimer\u2019s Disease. Mol Neurobiol., 53(7), 4328\u20134342. https:\/\/doi.org\/10.1007\/s12035-015-9369-x.","journal-title":"Mol Neurobiol."},{"issue":"4","key":"10068_CR62","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/mds.25824","volume":"29","author":"E Tolosa","year":"2014","unstructured":"Tolosa, E., Litvan, I., H\u00f6glinger, G. U., et al. (2014). A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy. Mov Disord., 29(4), 470\u2013478. https:\/\/doi.org\/10.1002\/mds.25824.","journal-title":"Mov Disord."},{"issue":"4","key":"10068_CR63","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/mds.25815","volume":"29","author":"GU H\u00f6glinger","year":"2014","unstructured":"H\u00f6glinger, G. U., Huppertz, H.-J., Wagenpfeil, S., et al. (2014). Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial. Mov Disord., 29(4), 479\u2013487. https:\/\/doi.org\/10.1002\/mds.25815.","journal-title":"Mov Disord."},{"issue":"1","key":"10068_CR64","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3233\/JAD-2012-120805","volume":"33","author":"T del Ser","year":"2013","unstructured":"del Ser, T., Steinwachs, K. C., Gertz, H. J., et al. (2013). Treatment of Alzheimer\u2019s disease with the GSK-3 inhibitor tideglusib: a pilot study. J Alzheimers Dis., 33(1), 205\u2013215. https:\/\/doi.org\/10.3233\/JAD-2012-120805.","journal-title":"J Alzheimers Dis."},{"issue":"1","key":"10068_CR65","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/JAD-141959","volume":"45","author":"S Lovestone","year":"2015","unstructured":"Lovestone, S., Boada, M., Dubois, B., et al. (2015). A phase II trial of tideglusib in Alzheimer\u2019s disease. J Alzheimers Dis., 45(1), 75\u201388. https:\/\/doi.org\/10.3233\/JAD-141959.","journal-title":"J Alzheimers Dis."},{"issue":"9","key":"10068_CR66","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","volume":"19","author":"MA Ellul","year":"2020","unstructured":"Ellul, M. A., Benjamin, L., Singh, B., et al. (2020). Neurological associations of COVID-19. Lancet Neurol., 19(9), 767\u2013783. https:\/\/doi.org\/10.1016\/S1474-4422(20)30221-0.","journal-title":"Lancet Neurol."},{"key":"10068_CR67","doi-asserted-by":"publisher","unstructured":"Ramani, A., M\u00fcller, L., Ostermann, P, N., et al. (2020). SARS-CoV-2 targets neurons of 3D human brain organoids.\u00a0EMBO J,\u00a039(20):e106230. https:\/\/doi.org\/10.15252\/embj.2020106230.\u00a0","DOI":"10.15252\/embj.2020106230"},{"key":"10068_CR68","doi-asserted-by":"publisher","unstructured":"Song, E., Zhang, C., Israelow, B., et al. Neuroinvasive potential of SARS-CoV-2 revealed in a human brain organoid model. 2020. https:\/\/doi.org\/10.1101\/2020.06.25.169946. bioRxiv preprint","DOI":"10.1101\/2020.06.25.169946"},{"issue":"7","key":"10068_CR69","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.4103\/1673-5374.272574","volume":"15","author":"S Bagnato","year":"2020","unstructured":"Bagnato, S., & Boccagni, C. (2020). Moderate\/severe traumatic brain injury as a trigger of chronic neurodegeneration in humans. Neural Regen Res., 15(7), 1247\u20131248. https:\/\/doi.org\/10.4103\/1673-5374.272574.","journal-title":"Neural Regen Res."},{"key":"10068_CR70","doi-asserted-by":"publisher","unstructured":"Lai, J, D., Berlind, J, E., Fricklas, G., et al. A model of traumatic brain injury using human iPSC-derived cortical brain organoids. 2020. https:\/\/doi.org\/10.1101\/2020.07.05.180299. bioRxiv preprint","DOI":"10.1101\/2020.07.05.180299"},{"issue":"2","key":"10068_CR71","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41593-017-0066-0","volume":"21","author":"N Li","year":"2018","unstructured":"Li, N., & Lagier-Tourenne, C. (2018). Nuclear pores: the gate to neurodegeneration. Nat Neurosci., 21(2), 156\u2013158. https:\/\/doi.org\/10.1038\/s41593-017-0066-0.","journal-title":"Nat Neurosci."},{"issue":"2","key":"10068_CR72","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrn3887","volume":"16","author":"J Brettschneider","year":"2015","unstructured":"Brettschneider, J., Del Tredici, K., Lee, V. M.-Y., & Trojanowski, J. Q. (2015). Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat Rev Neurosci., 16(2), 109\u2013120. https:\/\/doi.org\/10.1038\/nrn3887.","journal-title":"Nat Rev Neurosci."},{"key":"10068_CR73","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jprot.2018.04.032","volume":"182","author":"M Chen","year":"2018","unstructured":"Chen, M., Lee, H.-K., Moo, L., Hanlon, E., Stein, T., & Xia, W. (2018). Common proteomic profiles of induced pluripotent stem cell-derived three-dimensional neurons and brain tissue from Alzheimer patients. J Proteomics., 182, 21\u201333. https:\/\/doi.org\/10.1016\/j.jprot.2018.04.032.","journal-title":"J Proteomics."},{"issue":"3","key":"10068_CR74","doi-asserted-by":"publisher","first-page":"176","DOI":"10.15252\/emmm.201505894","volume":"8","author":"D Brunetti","year":"2016","unstructured":"Brunetti, D., Torsvik, J., Dallabona, C., et al. (2016). Defective PITRM 1 mitochondrial peptidase is associated with A\u03b2 amyloidotic neurodegeneration. EMBO Mol Med., 8(3), 176\u2013190.","journal-title":"EMBO Mol Med."},{"key":"10068_CR75","doi-asserted-by":"publisher","unstructured":"Ivanyuk, D., P\u00e9rez, M, J., Panagiotakopoulou, V., et al. Loss of function of the mitochondrial peptidase PITRM1 induces proteotoxic stress and Alzheimer\u2019 s disease-like pathology in human cerebral organoids. 2020. https:\/\/doi.org\/10.1101\/2020.01.27.919522. bioRxiv preprint","DOI":"10.1101\/2020.01.27.919522"},{"issue":"38","key":"10068_CR76","doi-asserted-by":"publisher","first-page":"19165","DOI":"10.1073\/pnas.1904563116","volume":"116","author":"Y Zhu","year":"2019","unstructured":"Zhu, Y., Li, C., Tao, X., et al. (2019). Nmnat restores neuronal integrity by neutralizing mutant Huntingtin aggregate-induced progressive toxicity. Proc Natl Acad Sci U S A., 116(38), 19165\u201319175. https:\/\/doi.org\/10.1073\/pnas.1904563116.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"10068_CR77","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0002-9440(10)64538-5","volume":"157","author":"AM Cataldo","year":"2000","unstructured":"Cataldo, A. M., Peterhoff, C. M., Troncoso, J. C., Gomez-isla, T., Hyman, B. T., & Nixon, R. A. (2000). Endocytic Pathway Abnormalities Precede Amyloid Endocytic Pathway Abnormalities Precede Amyloid \u03b2 Deposition in Sporadic Alzheimer\u2019s Disease and Down Syndrome. Am J Pathol., 157(1), 277\u2013286.","journal-title":"Am J Pathol."},{"issue":"6","key":"10068_CR78","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008.APOE4","volume":"98","author":"YT Lin","year":"2018","unstructured":"Lin, Y. T., Seo, J., Gao, F., et al. (2018). APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC- derived brain cell types. Neuron., 98(6), 1141\u20131154. https:\/\/doi.org\/10.1016\/j.neuron.2018.05.008.APOE4.","journal-title":"Neuron."},{"issue":"2","key":"10068_CR79","doi-asserted-by":"publisher","first-page":"235","DOI":"10.15252\/embj.201797128","volume":"37","author":"A Jimenez-Orgaz","year":"2018","unstructured":"Jimenez-Orgaz, A., Kvainickas, A., N\u00e4gele, H., et al. (2018). Control of RAB7 activity and localization through the retromer-TBC1D5 complex enables RAB7-dependent mitophagy. EMBO Journal, 37(2), 235\u2013254. https:\/\/doi.org\/10.15252\/embj.201797128.","journal-title":"EMBO Journal"},{"issue":"8","key":"10068_CR80","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1080\/15548627.2018.1482148","volume":"14","author":"C Puri","year":"2018","unstructured":"Puri, C., Vicinanza, M., & Rubinsztein, D. C. (2018). Phagophores evolve from recycling endosomes. Autophagy., 14(8), 1475\u20131477. https:\/\/doi.org\/10.1080\/15548627.2018.1482148.","journal-title":"Autophagy."},{"issue":"13-14","key":"10068_CR81","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1089\/ten.TEA.2017.0423","volume":"24","author":"Y Yan","year":"2018","unstructured":"Yan, Y., Song, L., Bejoy, J., et al. (2018). Modeling Neurodegenerative Microenvironment Using Cortical Organoids Derived from Human Stem Cells. Tissue Eng Part A., 24(13-14), 1125\u20131137. https:\/\/doi.org\/10.1089\/ten.TEA.2017.0423.","journal-title":"Tissue Eng Part A."},{"key":"10068_CR82","doi-asserted-by":"publisher","first-page":"134433","DOI":"10.1016\/j.neulet.2019.134433","volume":"711","author":"W Fan","year":"2019","unstructured":"Fan, W., Sun, Y., Shi, Z., Wang, H., & Deng, J. (2019). Mouse induced pluripotent stem cells-derived Alzheimer\u2019s disease cerebral organoid culture and neural differentiation disorders. Neurosci Lett., 711, 134433. https:\/\/doi.org\/10.1016\/j.neulet.2019.134433.","journal-title":"Neurosci Lett."},{"issue":"7","key":"10068_CR83","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41593-018-0175-4","volume":"21","author":"J Park","year":"2018","unstructured":"Park, J., Wetzel, I., Marriott, I., et al. (2018). A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer\u2019s disease. Nat Neurosci., 21(7), 941\u2013951. https:\/\/doi.org\/10.1038\/s41593-018-0175-4.","journal-title":"Nat Neurosci."},{"issue":"1","key":"10068_CR84","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2019.09.032","volume":"104","author":"AL Barth","year":"2019","unstructured":"Barth, A. L., & Ray, A. (2019). Progressive Circuit Changes during Learning and Disease. Neuron., 104(1), 37\u201346. https:\/\/doi.org\/10.1016\/j.neuron.2019.09.032.","journal-title":"Neuron."},{"key":"10068_CR85","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.pharmthera.2018.11.006","volume":"195","author":"Y Chen","year":"2019","unstructured":"Chen, Y., Fu, A. K. Y., & Ip, N. Y. (2019). Synaptic dysfunction in Alzheimer\u2019s disease: Mechanisms and therapeutic strategies. Pharmacol Ther., 195, 186\u2013198. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.11.006.","journal-title":"Pharmacol Ther."},{"key":"10068_CR86","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3389\/fnins.2019.00735","volume":"13","author":"J Jackson","year":"2019","unstructured":"Jackson, J., Jambrina, E., Li, J., et al. (2019). Targeting the Synapse in Alzheimer\u2019s Disease. Front Neurosci., 13, 735. https:\/\/doi.org\/10.3389\/fnins.2019.00735.","journal-title":"Front Neurosci."},{"issue":"6","key":"10068_CR87","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/jnc.15007","volume":"154","author":"S Li","year":"2020","unstructured":"Li, S., & Selkoe, D. J. (2020). A mechanistic hypothesis for the impairment of synaptic plasticity by soluble A\u03b2 oligomers from Alzheimer\u2019s brain. J Neurochem., 154(6), 583\u2013597. https:\/\/doi.org\/10.1111\/jnc.15007.","journal-title":"J Neurochem."},{"issue":"12","key":"10068_CR88","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrn.2016.141","volume":"17","author":"JJ Palop","year":"2016","unstructured":"Palop, J. J., & Mucke, L. (2016). Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci., 17(12), 777\u2013792. https:\/\/doi.org\/10.1038\/nrn.2016.141.","journal-title":"Nat Rev Neurosci."},{"key":"10068_CR89","doi-asserted-by":"publisher","unstructured":"Ghatak, S., Dolatabadi, N., Trudler, D., et al. Mechanisms of hyperexcitability in Alzheimer\u2019s disease hiPSC-derived neurons and cerebral organoids vs isogenic controls. Elife. 2019;8. https:\/\/doi.org\/10.7554\/eLife.50333","DOI":"10.7554\/eLife.50333"},{"issue":"3","key":"10068_CR90","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188.Blood","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney, M. D., Sagare, A. P., Zlokovic, B. V., & Angeles, L. (2018). Blood\u2013brain barrier breakdown in Alzheimer\u2019s disease and other neurodegenerative disorders. Nat Rev Neurol., 14(3), 133\u2013150. https:\/\/doi.org\/10.1038\/nrneurol.2017.188.Blood.","journal-title":"Nat Rev Neurol."},{"key":"10068_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/advs.201900962","volume":"1900962","author":"Y Shin","year":"2019","unstructured":"Shin, Y., Choi, S. H., Kim, E., et al. (2019). Blood \u2013 Brain Barrier Dysfunction in a 3D In Vitro Model of Alzheimer \u2019 s Disease. 3D Alzheimer\u2019s Dis Model, 1900962, 1\u201310. https:\/\/doi.org\/10.1002\/advs.201900962.","journal-title":"3D Alzheimer\u2019s Dis Model"},{"issue":"5","key":"10068_CR92","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.biomaterials.2013.11.028","volume":"35","author":"D Zhang","year":"2014","unstructured":"Zhang, D., Pekkanen-Mattila, M., Shahsavani, M., Falk, A., Teixeira, A. I., & Herland, A. (2014). A 3D Alzheimer\u2019s disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons. Biomaterials., 35(5), 1420\u20131428. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.11.028.","journal-title":"Biomaterials."},{"issue":"2","key":"10068_CR93","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nn1630","volume":"9","author":"L Zhao","year":"2005","unstructured":"Zhao, L., Ma, Q.-L., Calon, F., et al. (2005). Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nat Neurosci., 9(2), 234\u2013242. https:\/\/doi.org\/10.1038\/nn1630.","journal-title":"Nat Neurosci."},{"issue":"3","key":"10068_CR94","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.stemcr.2016.08.001","volume":"7","author":"MC Silva","year":"2016","unstructured":"Silva, M. C., Cheng, C., Mair, W., et al. (2016). Human iPSC-Derived Neuronal Model of Tau-A152T Frontotemporal Dementia Reveals Tau-Mediated Mechanisms of Neuronal Vulnerability. Stem Cell Reports., 7(3), 325\u2013340. https:\/\/doi.org\/10.1016\/j.stemcr.2016.08.001.","journal-title":"Stem Cell Reports."},{"issue":"7652","key":"10068_CR95","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature22047.Cell","volume":"545","author":"G Quadrato","year":"2017","unstructured":"Quadrato, G., Nguyen, T., Macosko, E. Z., et al. (2017). Cell Diversity and Network Dynamics in Photosensitive Human Brain Organoids. Nature., 545(7652), 48\u201353. https:\/\/doi.org\/10.1038\/nature22047.Cell.","journal-title":"Nature."},{"issue":"3","key":"10068_CR96","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.stem.2017.07.007","volume":"21","author":"Y Xiang","year":"2017","unstructured":"Xiang, Y., Tanaka, Y., Patterson, B., et al. (2017). Fusion of Regionally Specified hPSC-Derived Organoids Models Human Brain Development and Interneuron Migration. Cell Stem Cell, 21(3), 383\u2013398.e7. https:\/\/doi.org\/10.1016\/j.stem.2017.07.007.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10068_CR97","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.stem.2013.11.006","volume":"13","author":"JD Miller","year":"2013","unstructured":"Miller, J. D., Ganat, Y. M., Kishinevsky, S., et al. (2013). Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell., 13(6), 691\u2013705. https:\/\/doi.org\/10.1016\/j.stem.2013.11.006.","journal-title":"Cell Stem Cell."},{"key":"10068_CR98","doi-asserted-by":"publisher","unstructured":"Janssens, S., Schotsaert, M., Karnik, R., et al. (2018). Zika Virus Alters DNA Methylation of Neural Genes in an Organoid Model of the Developing Human Brain. mSystems, 3(1). https:\/\/doi.org\/10.1128\/mSystems.00219-17.","DOI":"10.1128\/mSystems.00219-17"},{"issue":"10","key":"10068_CR99","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9.Protein","volume":"21","author":"C Soto","year":"2018","unstructured":"Soto, C., & Pritzkow, S. (2018). Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci., 21(10), 1332\u20131340. https:\/\/doi.org\/10.1038\/s41593-018-0235-9.Protein.","journal-title":"Nat Neurosci."},{"key":"10068_CR100","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.taap.2018.02.003.Rotenone","volume":"354","author":"D Pamies","year":"2018","unstructured":"Pamies, D., Block, K., Lau, P., et al. (2018). Rotenone exerts developmental neurotoxicity in a human brain spheroid model. Toxicol Appl Pharmacol., 354, 101\u2013114. https:\/\/doi.org\/10.1016\/j.taap.2018.02.003.Rotenone.","journal-title":"Toxicol Appl Pharmacol."},{"key":"10068_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/799692","volume":"217","author":"SG Zambuto","year":"2019","unstructured":"Zambuto, S. G., Serrano, J. F., Vilbert, A. C., Lu, Y., & Harley, B. A. C. (2019). Pedron S. Response of neuroglia to hypoxia-induced oxidative stress using enzymatically crosslinked hydrogels., 217, 1\u201327. https:\/\/doi.org\/10.1101\/799692.","journal-title":"Response of neuroglia to hypoxia-induced oxidative stress using enzymatically crosslinked hydrogels."},{"issue":"4","key":"10068_CR102","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.celrep.2016.09.062.GENERATING","volume":"17","author":"E Vera","year":"2016","unstructured":"Vera, E., Bosco, N., & Studer, L. (2016). Generating late-onset human IPSC-based disease models by inducing neuronal age-related phenotypes through telomerase manipulation. Cell Rep., 17(4), 1184\u20131192. https:\/\/doi.org\/10.1016\/j.celrep.2016.09.062.GENERATING.","journal-title":"Cell Rep."},{"key":"10068_CR103","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1007\/s12035-017-0610-7","volume":"55","author":"MS Ahmed","year":"2018","unstructured":"Ahmed, M. S., Ikram, S., Bibi, N., & Mir, A. (2018). Hutchinson \u2013 Gilford Progeria Syndrome: A Premature Aging Disease. Mol Neurobiol., 55, 4417\u20134427. https:\/\/doi.org\/10.1007\/s12035-017-0610-7.","journal-title":"Mol Neurobiol."},{"issue":"4167","key":"10068_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-06684-2","volume":"9","author":"PR Ormel","year":"2018","unstructured":"Ormel, P. R., De S\u00e1, R. V., Van Bodegraven, E. J., et al. (2018). Microglia innately develop within cerebral organoids. Nat Commun., 9(4167), 1\u201314. https:\/\/doi.org\/10.1038\/s41467-018-06684-2.","journal-title":"Nat Commun."},{"key":"10068_CR105","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.neuron.2017.07.035","volume":"95","author":"SA Sloan","year":"2017","unstructured":"Sloan, S. A., Darmanis, S., Huber, N., et al. (2017). Human Astrocyte Maturation Captured in 3D Cerebral Cortical Spheroids Derived from Pluripotent Stem Cells. Neuron., 95, 779\u2013790. https:\/\/doi.org\/10.1016\/j.neuron.2017.07.035.","journal-title":"Neuron."},{"issue":"1","key":"10068_CR106","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13024-018-0297-x","volume":"13","author":"A McQuade","year":"2018","unstructured":"McQuade, A., Coburn, M., Tu, C. H., Hasselmann, J., Davtyan, H., & Blurton-Jones, M. (2018). Development and validation of a simplified method to generate human microglia from pluripotent stem cells. Mol Neurodegener., 13(1), 67. https:\/\/doi.org\/10.1186\/s13024-018-0297-x.","journal-title":"Mol Neurodegener."},{"key":"10068_CR107","doi-asserted-by":"publisher","unstructured":"Schmunk, G., Kim, CN., Soliman, S, S., et al. Human microglia upregulate cytokine signatures and accelerate maturation of neural networks. 2020. https:\/\/doi.org\/10.1101\/2020.03.24.006874","DOI":"10.1101\/2020.03.24.006874"},{"key":"10068_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14573\/altex.1911111","volume":"37","author":"M Br\u00fcll","year":"2020","unstructured":"Br\u00fcll, M., Spreng, A., Gutbier, S., et al. (2020). Incorporation of Stem Cell-Derived Astrocytes into Neuronal Organoids to Allow Neuro-Glial Interactions in Toxicological Studies. ALTEX - Altern to Anim Exp, 37, 1\u201320. https:\/\/doi.org\/10.14573\/altex.1911111.","journal-title":"ALTEX - Altern to Anim Exp"},{"issue":"3","key":"10068_CR109","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41593-018-0316-9","volume":"22","author":"RM Marton","year":"2019","unstructured":"Marton, R. M., Miura, Y., Sloan, S. A., et al. (2019). Differentiation and maturation of oligodendrocytes in human three-dimensional neural cultures. Nat Neurosci., 22(3), 484\u2013491. https:\/\/doi.org\/10.1038\/s41593-018-0316-9.","journal-title":"Nat Neurosci."},{"issue":"9","key":"10068_CR110","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41592-018-0081-4","volume":"15","author":"M Madhavan","year":"2018","unstructured":"Madhavan, M., Nevin, Z. S., Shick, H. E., et al. (2018). Induction of myelinating oligodendrocytes in human cortical spheroids. Nat Methods., 15(9), 700\u2013706. https:\/\/doi.org\/10.1038\/s41592-018-0081-4.","journal-title":"Nat Methods."},{"issue":"10","key":"10068_CR111","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/nprot.2014.158","volume":"9","author":"MA Lancaster","year":"2014","unstructured":"Lancaster, M. A., & Knoblich, J. A. (2014). Generation of cerebral organoids from human pluripotent stem cells. Nat Protoc., 9(10), 2329\u20132340. https:\/\/doi.org\/10.1038\/nprot.2014.158.","journal-title":"Nat Protoc."},{"key":"10068_CR112","doi-asserted-by":"publisher","unstructured":"Cai, H., Ao, Z., Hu, L., et al. Acoustofluidic Assembly of 3D Neurospheroids to Model Alzheimer\u2019s Disease. 2020. https:\/\/doi.org\/10.1101\/2020.03.03.972299","DOI":"10.1101\/2020.03.03.972299"},{"issue":"7652","key":"10068_CR113","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nature22330.Assembly","volume":"545","author":"F Birey","year":"2017","unstructured":"Birey, F., Andersen, J., Makinson, C. D., et al. (2017). Assembly of functionally integrated human forebrain spheroids. Nature., 545(7652), 54\u201359. https:\/\/doi.org\/10.1038\/nature22330.Assembly.","journal-title":"Nature."},{"issue":"5","key":"10068_CR114","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.stemcr.2017.03.010","volume":"8","author":"AS Monzel","year":"2017","unstructured":"Monzel, A. S., Smits, L. M., Hemmer, K., et al. (2017). Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells. Stem cell reports., 8(5), 1144\u20131154. https:\/\/doi.org\/10.1016\/j.stemcr.2017.03.010.","journal-title":"Stem cell reports."},{"issue":"3172","key":"10068_CR115","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1039\/c8lc00206a","volume":"18","author":"E Berger","year":"2018","unstructured":"Berger, E., Magliaro, C., Paczia, N., et al. (2018). Millifluidic culture improves human midbrain organoid vitality and differentiation. Lab Chip., 18(3172), 3172\u20133183. https:\/\/doi.org\/10.1039\/c8lc00206a.","journal-title":"Lab Chip."},{"issue":"3","key":"10068_CR116","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nprot.2017.152","volume":"13","author":"X Qian","year":"2018","unstructured":"Qian, X., Jacob, F., Song, M. M., Nguyen, H. N., Song, H., & Ming, G.-L. (2018). Generation of human brain region-specific organoids using a miniaturized spinning bioreactor. Nat Protoc., 13(3), 565\u2013580. https:\/\/doi.org\/10.1038\/nprot.2017.152.","journal-title":"Nat Protoc."},{"issue":"7","key":"10068_CR117","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/WNR.0000000000001014","volume":"29","author":"MT Pham","year":"2018","unstructured":"Pham, M. T., Pollock, K. M., Rose, M. D., et al. (2018). Generation of human vascularized brain organoids. Neuroreport., 29(7), 588\u2013593. https:\/\/doi.org\/10.1097\/WNR.0000000000001014.","journal-title":"Neuroreport."},{"issue":"3","key":"10068_CR118","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1073\/pnas.0807583106","volume":"106","author":"A Ferdous","year":"2009","unstructured":"Ferdous, A., Caprioli, A., Iacovino, M., et al. (2009). Nkx2-5 transactivates the Ets-related protein 71 gene and specifies an endothelial\/endocardial fate in the developing embryo. Proc Natl Acad Sci U S A., 106(3), 814\u2013819. https:\/\/doi.org\/10.1073\/pnas.0807583106.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"11","key":"10068_CR119","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41592-019-0586-5","volume":"16","author":"B Cakir","year":"2019","unstructured":"Cakir, B., Xiang, Y., Tanaka, Y., et al. (2019). Engineering of human brain organoids with a functional vascular-like system. Nat Methods., 16(11), 1169\u20131175. https:\/\/doi.org\/10.1038\/s41592-019-0586-5.","journal-title":"Nat Methods."},{"issue":"5","key":"10068_CR120","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nbt.4127","volume":"36","author":"AA Mansour","year":"2018","unstructured":"Mansour, A. A., Gon\u00e7alves, J. T., Bloyd, C. W., et al. (2018). An in vivo model of functional and vascularized human brain organoids. Nat Biotechnol., 36(5), 432\u2013441. https:\/\/doi.org\/10.1038\/nbt.4127.","journal-title":"Nat Biotechnol."},{"issue":"6","key":"10068_CR121","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s12264-019-00384-7","volume":"35","author":"Y Li","year":"2019","unstructured":"Li, Y., Sun, X., Liu, H., et al. (2019). Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs. Neurosci Bull., 35(6), 996\u20131010. https:\/\/doi.org\/10.1007\/s12264-019-00384-7.","journal-title":"Neurosci Bull."},{"issue":"1","key":"10068_CR122","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/bit.26045","volume":"114","author":"YI Wang","year":"2017","unstructured":"Wang, Y. I., Abaci, H. E., & Shuler, M. L. (2017). Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening. Biotechnol Bioeng., 114(1), 184\u2013194. https:\/\/doi.org\/10.1002\/bit.26045.","journal-title":"Biotechnol Bioeng."},{"key":"10068_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciadv.aau7375","volume":"5","author":"MJ Stebbins","year":"2019","unstructured":"Stebbins, M. J., Gastfriend, B. D., Canfield, S. G., et al. (2019). Human pluripotent stem cell \u2013 derived brain pericyte \u2013 like cells induce blood-brain barrier properties. Sci Adv., 5, 1\u201316.","journal-title":"Sci Adv."},{"key":"10068_CR124","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.biomaterials.2018.07.014","volume":"180","author":"M Campisi","year":"2018","unstructured":"Campisi, M., Shin, Y., Osaki, T., Hajal, C., Chiono, V., & Kamm, R. D. (2018). 3D self-organized microvascular model of the human blood-brain barrier with endothelial cells, pericytes and astrocytes. Biomaterials., 180, 117\u2013129. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.07.014.","journal-title":"Biomaterials."},{"issue":"6","key":"10068_CR125","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/jnc.13923","volume":"140","author":"SG Canfield","year":"2017","unstructured":"Canfield, S. G., Stebbins, M. J., Morales, B. S., et al. (2017). An isogenic blood-brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells. J Neurochem., 140(6), 874\u2013888. https:\/\/doi.org\/10.1111\/jnc.13923.","journal-title":"J Neurochem."},{"issue":"6","key":"10068_CR126","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.stem.2019.05.011","volume":"24","author":"GD Vatine","year":"2019","unstructured":"Vatine, G. D., Barrile, R., Workman, M. J., et al. (2019). Human iPSC-Derived Blood-Brain Barrier Chips Enable Disease Modeling and Personalized Medicine Applications. Cell Stem Cell, 24(6), 995\u20131005.e6. https:\/\/doi.org\/10.1016\/j.stem.2019.05.011.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10068_CR127","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.stem.2019.08.002","volume":"25","author":"CA Trujillo","year":"2019","unstructured":"Trujillo, C. A., Gao, R., Negraes, P. D., et al. (2019). Complex Oscillatory Waves Emerging from Cortical Organoids Model Early Human Brain Network Development. Cell Stem Cell, 25(4), 558\u2013569.e7. https:\/\/doi.org\/10.1016\/j.stem.2019.08.002.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10068_CR128","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.celrep.2019.01.023","volume":"26","author":"K Meyer","year":"2019","unstructured":"Meyer, K., Feldman, H. M., Lu, T., et al. (2019). REST and Neural Gene Network Dysregulation in iPSC Models of Alzheimer\u2019s Disease. Cell Reports, 26(5), 1112\u20131127.e9. https:\/\/doi.org\/10.1016\/j.celrep.2019.01.023.","journal-title":"Cell Reports"},{"key":"10068_CR129","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41586-019-1654-9","volume":"574","author":"S Kanton","year":"2019","unstructured":"Kanton, S., Boyle, M. J., He, Z., et al. (2019). Organoid single-cell genomic atlas uncovers human-specific features of brain development. Nature., 574, 418\u2013421.","journal-title":"Nature."},{"issue":"7761","key":"10068_CR130","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys, H., Davila-Velderrain, J., Peng, Z., et al. (2019). Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature., 570(7761), 332\u2013337. https:\/\/doi.org\/10.1038\/s41586-019-1195-2.","journal-title":"Nature."},{"issue":"1","key":"10068_CR131","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-020-00733-6","volume":"12","author":"A Kathuria","year":"2020","unstructured":"Kathuria, A., Lopez-Lengowski, K., Vater, M., McPhie, D., Cohen, B. M., & Karmacharya, R. (2020). Transcriptome analysis and functional characterization of cerebral organoids in bipolar disorder. Genome Med., 12(1), 34. https:\/\/doi.org\/10.1186\/s13073-020-00733-6.","journal-title":"Genome Med."},{"issue":"7","key":"10068_CR132","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamapsychiatry.2020.0196","volume":"77","author":"A Kathuria","year":"2020","unstructured":"Kathuria, A., Lopez-Lengowski, K., Jagtap, S. S., et al. (2020). Transcriptomic Landscape and Functional Characterization of Induced Pluripotent Stem Cell-Derived Cerebral Organoids in Schizophrenia. JAMA psychiatry., 77(7), 745\u2013754. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.0196.","journal-title":"JAMA psychiatry."},{"key":"10068_CR133","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13229-017-0124-1","volume":"8","author":"P Wang","year":"2017","unstructured":"Wang, P., Mokhtari, R., Pedrosa, E., et al. (2017). CRISPR\/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells. Mol Autism., 8, 11. https:\/\/doi.org\/10.1186\/s13229-017-0124-1.","journal-title":"Mol Autism."},{"key":"10068_CR134","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41576-019-0129-z","volume":"20","author":"DJ Burgess","year":"2019","unstructured":"Burgess, D. J. (2019). S\u00adpa\u00adti\u00adal t\u00adra\u00adns\u00adcriptomics coming of age. Nat Rev Genet., 20, 317. https:\/\/doi.org\/10.1038\/s41576-019-0129-z.","journal-title":"Nat Rev Genet."},{"key":"10068_CR135","doi-asserted-by":"publisher","unstructured":"Chen, W., Lu, A., Craessaerts, K., Pavie, B., Frigerio, C, S.. Spatial and temporal transcriptomics reveal microglia-astroglia crosstalk in the amyloid- \u03b2 plaque cell niche of Alzheimer\u2019s disease. 2019. https:\/\/doi.org\/10.1101\/719930","DOI":"10.1101\/719930"},{"issue":"6","key":"10068_CR136","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jalz.2015.11.002","volume":"12","author":"DC Hondius","year":"2016","unstructured":"Hondius, D. C., van Nierop, P., Li, K. W., et al. (2016). Profiling the human hippocampal proteome at all pathologic stages of Alzheimer\u2019s disease. Alzheimers Dement., 12(6), 654\u2013668. https:\/\/doi.org\/10.1016\/j.jalz.2015.11.002.","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10068_CR137","doi-asserted-by":"publisher","first-page":"9115","DOI":"10.1038\/s41598-017-09481-x","volume":"7","author":"M Lach\u00e9n-Montes","year":"2017","unstructured":"Lach\u00e9n-Montes, M., Gonz\u00e1lez-Morales, A., Zelaya, M. V., et al. (2017). Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer\u2019s disease progression. Sci Rep., 7(1), 9115. https:\/\/doi.org\/10.1038\/s41598-017-09481-x.","journal-title":"Sci Rep."},{"issue":"9","key":"10068_CR138","doi-asserted-by":"publisher","first-page":"e0163072","DOI":"10.1371\/journal.pone.0163072","volume":"11","author":"H-K Lee","year":"2016","unstructured":"Lee, H.-K., Velazquez Sanchez, C., Chen, M., et al. (2016). Three Dimensional Human Neuro-Spheroid Model of Alzheimer\u2019s Disease Based on Differentiated Induced Pluripotent Stem Cells. PLoS One., 11(9), e0163072. https:\/\/doi.org\/10.1371\/journal.pone.0163072.","journal-title":"PLoS One."},{"key":"10068_CR139","doi-asserted-by":"publisher","unstructured":"Mcclure-begley, T, D., Ebmeier, C, C., Ball, K, E., Jacobsen, J, R. Cerebral organoid proteomics reveals signatures of dysregulated cortical development associated with human trisomy 21. 2018. https:\/\/doi.org\/10.1101\/315317","DOI":"10.1101\/315317"},{"issue":"4","key":"10068_CR140","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.euroneuro.2015.01.008","volume":"25","author":"JC Bouso","year":"2015","unstructured":"Bouso, J. C., Palhano-fontes, F., Rodr\u00edguez-fornells, A., et al. (2015). Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans $. Eur Neuropsychopharmacol., 25(4), 483\u2013492. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.01.008.","journal-title":"Eur Neuropsychopharmacol."},{"issue":"1","key":"10068_CR141","doi-asserted-by":"publisher","first-page":"12863","DOI":"10.1038\/s41598-017-12779-5","volume":"7","author":"V Dakic","year":"2017","unstructured":"Dakic, V., Minardi Nascimento, J., Costa Sartore, R., et al. (2017). Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT. Sci Rep., 7(1), 12863. https:\/\/doi.org\/10.1038\/s41598-017-12779-5.","journal-title":"Sci Rep."},{"issue":"1-2","key":"10068_CR142","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1023\/A:1013713905833","volume":"48","author":"O Fiehn","year":"2002","unstructured":"Fiehn, O. (2002). Metabolomics--the link between genotypes and phenotypes. Plant Mol Biol., 48(1-2), 155\u2013171.","journal-title":"Plant Mol Biol."},{"issue":"7","key":"10068_CR143","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25.Metabolomics","volume":"17","author":"CH Johnson","year":"2016","unstructured":"Johnson, C. H., Ivanisevic, J., & Siuzdak, G. (2016). Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol., 17(7), 451\u2013459. https:\/\/doi.org\/10.1038\/nrm.2016.25.Metabolomics.","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"4","key":"10068_CR144","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrm3314","volume":"13","author":"GJ Patti","year":"2012","unstructured":"Patti, G. J., Yanes, O., & Siuzdak, G. (2012). Innovation: Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol., 13(4), 263\u2013269. https:\/\/doi.org\/10.1038\/nrm3314.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"10068_CR145","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.chroma.2013.06.005","volume":"1302","author":"C Ibanez","year":"2013","unstructured":"Ibanez, C., Sim\u00f3, C., Barupal, D. K., et al. (2013). A new metabolomic workflow for early detection of Alzheimer\u2019s disease. J Chromatogr A., 1302, 65\u201371.","journal-title":"J Chromatogr A."},{"issue":"7","key":"10068_CR146","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jalz.2015.12.008","volume":"12","author":"R Casanova","year":"2016","unstructured":"Casanova, R., Varma, S., Simpson, B., et al. (2016). Blood metabolite markers of preclinical Alzheimer\u2019s disease in two longitudinally followed cohorts of older individuals. Alzheimer\u2019s Dement., 12(7), 815\u2013822. https:\/\/doi.org\/10.1016\/j.jalz.2015.12.008.","journal-title":"Alzheimer\u2019s Dement."},{"key":"10068_CR147","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jpba.2014.05.023","volume":"98","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2014","unstructured":"Gonz\u00e1lez-Dom\u00ednguez, R., Garc\u00eda-Barrera, T., & G\u00f3mez-Ariza, J. L. (2014). Metabolomic study of lipids in serum for biomarker discovery in Alzheimer\u2019s disease using direct infusion mass spectrometry. J Pharm Biomed Anal., 98, 321\u2013326. https:\/\/doi.org\/10.1016\/j.jpba.2014.05.023.","journal-title":"J Pharm Biomed Anal."},{"issue":"3","key":"10068_CR148","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jalz.2010.06.001","volume":"7","author":"R Kaddurah-Daouk","year":"2011","unstructured":"Kaddurah-Daouk, R., Rozen, S., Matson, W., et al. (2011). Metabolomic changes in autopsy-confirmed Alzheimer\u2019s disease. Alzheimers Dement., 7(3), 309\u2013317. https:\/\/doi.org\/10.1016\/j.jalz.2010.06.001.","journal-title":"Alzheimers Dement."},{"key":"10068_CR149","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jprot.2019.04.008","volume":"200","author":"C Pe\u00f1a-Bautista","year":"2019","unstructured":"Pe\u00f1a-Bautista, C., Roca, M., Herv\u00e1s, D., et al. (2019). Plasma metabolomics in early Alzheimer\u2019s disease patients diagnosed with amyloid biomarker. J Proteomics., 200, 144\u2013152. https:\/\/doi.org\/10.1016\/j.jprot.2019.04.008.","journal-title":"J Proteomics."},{"issue":"1","key":"10068_CR150","doi-asserted-by":"publisher","first-page":"e1002482","DOI":"10.1371\/journal.pmed.1002482","volume":"15","author":"VR Varma","year":"2018","unstructured":"Varma, V. R., Oommen, A. M., Varma, S., et al. (2018). Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study. PLoS Med., 15(1), e1002482. https:\/\/doi.org\/10.1371\/journal.pmed.1002482.","journal-title":"PLoS Med."},{"issue":"1","key":"10068_CR151","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s40478-019-0871-7","volume":"7","author":"G Gomez-Giro","year":"2019","unstructured":"Gomez-Giro, G., Arias-Fuenzalida, J., Jarazo, J., et al. (2019). Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis. Acta Neuropathol Commun., 7(1), 222. https:\/\/doi.org\/10.1186\/s40478-019-0871-7.","journal-title":"Acta Neuropathol Commun."},{"issue":"4","key":"10068_CR152","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1474-4422(17)30037-6","volume":"16","author":"BE Stopschinski","year":"2017","unstructured":"Stopschinski, B. E., & Diamond, M. I. (2017). The prion model for progression and diversity of neurodegenerative diseases. Lancet Neurol., 16(4), 323\u2013332. https:\/\/doi.org\/10.1016\/S1474-4422(17)30037-6.","journal-title":"Lancet Neurol."},{"issue":"12","key":"10068_CR153","first-page":"1","volume":"7","author":"BR Groveman","year":"2019","unstructured":"Groveman, B. R., Foliaki, S. T., Orru, C. D., et al. (2019). Sporadic Creutzfeldt-Jakob disease prion infection of human cerebral organoids. Acta Neuropathol Commun., 7(12), 1\u201312.","journal-title":"Acta Neuropathol Commun."},{"key":"10068_CR154","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.nbd.2017.06.005.Novel","volume":"106","author":"P Reilly","year":"2017","unstructured":"Reilly, P., Winston, C. N., Baron, K., Trejo, M., & Edward, M. (2017). Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation. Neurobiol Dis., 106, 222\u2013234. https:\/\/doi.org\/10.1016\/j.nbd.2017.06.005.Novel.","journal-title":"Neurobiol Dis."},{"key":"10068_CR155","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3389\/fnins.2019.00659","volume":"13","author":"X-Q Chen","year":"2019","unstructured":"Chen, X.-Q., & Mobley, W. C. (2019). Alzheimer Disease Pathogenesis: Insights From Molecular and Cellular Biology Studies of Oligomeric A\u03b2 and Tau Species. Front Neurosci., 13, 659. https:\/\/doi.org\/10.3389\/fnins.2019.00659.","journal-title":"Front Neurosci."},{"issue":"42","key":"10068_CR156","doi-asserted-by":"publisher","first-page":"14234","DOI":"10.1523\/JNEUROSCI.1523-15.2015","volume":"35","author":"M Usenovic","year":"2015","unstructured":"Usenovic, M., Niroomand, S., Drolet, R. E., et al. (2015). Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells. J Neurosci., 35(42), 14234\u201314250. https:\/\/doi.org\/10.1523\/JNEUROSCI.1523-15.2015.","journal-title":"J Neurosci."},{"issue":"1","key":"10068_CR157","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13195-018-0341-7","volume":"10","author":"C-L Dai","year":"2018","unstructured":"Dai, C.-L., Hu, W., Tung, Y. C., Liu, F., Gong, C.-X., & Iqbal, K. (2018). Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3\u2009\u00d7\u2009Tg-AD mice. Alzheimers Res Ther., 10(1), 13. https:\/\/doi.org\/10.1186\/s13195-018-0341-7.","journal-title":"Alzheimers Res Ther."},{"key":"10068_CR158","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/srep00700","volume":"2","author":"CA Lasagna-Reeves","year":"2012","unstructured":"Lasagna-Reeves, C. A., Castillo-Carranza, D. L., Sengupta, U., et al. (2012). Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau. Sci Rep., 2, 700. https:\/\/doi.org\/10.1038\/srep00700.","journal-title":"Sci Rep."},{"key":"10068_CR159","doi-asserted-by":"publisher","unstructured":"Tian, H., Davidowitz, E., Lopez, P., Emadi, S., Moe, J., & Sierks, M. (2013). Trimeric tau is toxic to human neuronal cells at low nanomolar concentrations. Int J Cell Biol., 2013. https:\/\/doi.org\/10.1155\/2013\/260787.","DOI":"10.1155\/2013\/260787"},{"issue":"1","key":"10068_CR160","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00401-018-1868-1","volume":"136","author":"MS Sinha","year":"2018","unstructured":"Sinha, M. S., Schultz, A. A., Civitelli, L., et al. (2018). Alzheimer\u2019s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers. Acta Neuropathol., 136(1), 41\u201356. https:\/\/doi.org\/10.1007\/s00401-018-1868-1.","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10068_CR161","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s00018-019-03349-1","volume":"77","author":"CA Brunello","year":"2020","unstructured":"Brunello, C. A., Merezhko, M., Uronen, R.-L., & Huttunen, H. J. (2020). Mechanisms of secretion and spreading of pathological tau protein. Cell Mol Life Sci., 77(9), 1721\u20131744. https:\/\/doi.org\/10.1007\/s00018-019-03349-1.","journal-title":"Cell Mol Life Sci."},{"issue":"5123","key":"10068_CR162","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"E Corder","year":"1993","unstructured":"Corder, E., Saunders, A., Strittmatter, W., et al. (1993). Gene Dose of Apolipoprotein and the Risk of Alzheimer \u2019 s Disease in Late Onset Families. Science (80), 261(5123), 921\u2013923.","journal-title":"Science (80)"},{"issue":"3","key":"10068_CR163","first-page":"1","volume":"9","author":"L Duan","year":"2014","unstructured":"Duan, L., Bhattacharyya, B. J., Belmadani, A., Pan, L., Miller, R. J., & Kessler, J. A. (2014). Stem cell derived basal forebrain cholinergic neurons from Alzheimer\u2019s disease patients are more susceptible to cell death. Mol Neurodegener., 9(3), 1\u201314.","journal-title":"Mol Neurodegener."},{"issue":"5","key":"10068_CR164","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"C Wang","year":"2018","unstructured":"Wang, C., Najm, R., Xu, Q., et al. (2018). Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat Med., 24(5), 647\u2013657. https:\/\/doi.org\/10.1038\/s41591-018-0004-z.","journal-title":"Nat Med."},{"issue":"6","key":"10068_CR165","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.stemcr.2017.10.015","volume":"9","author":"CR Muratore","year":"2017","unstructured":"Muratore, C. R., Zhou, C., Liao, M., et al. (2017). Cell-type Dependent Alzheimer\u2019s Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability. Stem cell reports., 9(6), 1868\u20131884. https:\/\/doi.org\/10.1016\/j.stemcr.2017.10.015.","journal-title":"Stem cell reports."},{"issue":"13","key":"10068_CR166","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1093\/hmg\/ddu064","volume":"23","author":"CR Muratore","year":"2014","unstructured":"Muratore, C. R., Rice, H. C., Srikanth, P., et al. (2014). The familial Alzheimer\u2019s disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons. Hum Mol Genet., 23(13), 3523\u20133536. https:\/\/doi.org\/10.1093\/hmg\/ddu064.","journal-title":"Hum Mol Genet."},{"key":"10068_CR167","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.celrep.2017.12.013","volume":"22","author":"A Virlogeux","year":"2018","unstructured":"Virlogeux, A., Moutaux, E., Christaller, W., Charlot, B., & Bruye, J. (2018). Reconstituting Corticostriatal Network on-a-Chip Reveals the Contribution of the Presynaptic Compartment to Huntington \u2019 s Disease. Cell Rep., 22, 110\u2013122. https:\/\/doi.org\/10.1016\/j.celrep.2017.12.013.","journal-title":"Cell Rep."},{"issue":"12","key":"10068_CR168","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41583-019-0231-4","volume":"20","author":"T Kn\u00f6pfel","year":"2019","unstructured":"Kn\u00f6pfel, T., & Song, C. (2019). Optical voltage imaging in neurons: moving from technology development to practical tool. Nat Rev Neurosci., 20(12), 719\u2013727. https:\/\/doi.org\/10.1038\/s41583-019-0231-4.","journal-title":"Nat Rev Neurosci."},{"issue":"1","key":"10068_CR169","doi-asserted-by":"publisher","first-page":"pdb.top066043","DOI":"10.1101\/pdb.top066043","volume":"2015","author":"JG Park","year":"2015","unstructured":"Park, J. G., & Palmer, A. E. (2015). Properties and use of genetically encoded FRET sensors for cytosolic and organellar Ca2+ measurements. Cold Spring Harbor Protocols, 2015(1), pdb.top066043. https:\/\/doi.org\/10.1101\/pdb.top066043.","journal-title":"Cold Spring Harbor Protocols"},{"issue":"1","key":"10068_CR170","doi-asserted-by":"publisher","first-page":"17874","DOI":"10.1038\/s41598-019-54248-1","volume":"9","author":"D Sood","year":"2019","unstructured":"Sood, D., Cairns, D. M., Dabbi, J. M., et al. (2019). Functional maturation of human neural stem cells in a 3D bioengineered brain model enriched with fetal brain-derived matrix. Sci Rep., 9(1), 17874. https:\/\/doi.org\/10.1038\/s41598-019-54248-1.","journal-title":"Sci Rep."},{"issue":"34","key":"10068_CR171","first-page":"1","volume":"12","author":"A Kathuria","year":"2020","unstructured":"Kathuria, A., Lopez-lengowski, K., Vater, M., Mcphie, D., & Cohen, B. M. (2020). Transcriptome analysis and functional characterization of cerebral organoids in bipolar disorder. Genome Med., 12(34), 1\u201316.","journal-title":"Genome Med."},{"issue":"10","key":"10068_CR172","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/nbt.2967","volume":"32","author":"AA Pollen","year":"2014","unstructured":"Pollen, A. A., Nowakowski, T. J., Shuga, J., et al. (2014). Low-coverage single-cell mRNA sequencing reveals cellular heterogeneity and activated signaling pathways in developing cerebral cortex. Nat Biotechnol., 32(10), 1053\u20131058. https:\/\/doi.org\/10.1038\/nbt.2967.","journal-title":"Nat Biotechnol."},{"issue":"11","key":"10068_CR173","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13229-017-0124-1","volume":"8","author":"P Wang","year":"2017","unstructured":"Wang, P., Mokhtari, R., Pedrosa, E., et al. (2017). CRISPR\/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells. Mol Autism., 8(11), 1\u201317. https:\/\/doi.org\/10.1186\/s13229-017-0124-1.","journal-title":"Mol Autism."},{"issue":"1","key":"10068_CR174","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13195-017-0318-y","volume":"9","author":"S Ostrowitzki","year":"2017","unstructured":"Ostrowitzki, S., Lasser, R. A., Dorflinger, E., et al. (2017). A phase III randomized trial of gantenerumab in prodromal Alzheimer\u2019s disease. Alzheimers Res Ther., 9(1), 95. https:\/\/doi.org\/10.1186\/s13195-017-0318-y.","journal-title":"Alzheimers Res Ther."},{"issue":"4","key":"10068_CR175","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa1705971","volume":"378","author":"LS Honig","year":"2018","unstructured":"Honig, L. S., Vellas, B., Woodward, M., et al. (2018). Trial of Solanezumab for Mild Dementia Due to Alzheimer\u2019s Disease. N Engl J Med., 378(4), 321\u2013330. https:\/\/doi.org\/10.1056\/NEJMoa1705971.","journal-title":"N Engl J Med."},{"issue":"21","key":"10068_CR176","doi-asserted-by":"publisher","first-page":"e1889","DOI":"10.1212\/WNL.0000000000005550","volume":"90","author":"JL Cummings","year":"2018","unstructured":"Cummings, J. L., Cohen, S., van Dyck, C. H., et al. (2018). ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease. Neurology., 90(21), e1889\u2013e1897. https:\/\/doi.org\/10.1212\/WNL.0000000000005550.","journal-title":"Neurology."},{"issue":"4","key":"10068_CR177","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJMoa1304839","volume":"370","author":"S Salloway","year":"2014","unstructured":"Salloway, S., Sperling, R., Fox, N. C., et al. (2014). Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease. N Engl J Med., 370(4), 322\u2013333. https:\/\/doi.org\/10.1056\/NEJMoa1304839.","journal-title":"N Engl J Med."},{"issue":"eaaz5626","key":"10068_CR178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/science.aaz5626","volume":"369","author":"L Pellegrini","year":"2020","unstructured":"Pellegrini, L., Bonfio, C., Chadwick, J., Begum, F., Skehel, M., & Lancaster, M. A. (2020). Human CNS barrier-forming organoids with cerebrospinal fluid production. Science (80- ), 369(eaaz5626), 1\u201312. https:\/\/doi.org\/10.1126\/science.aaz5626.","journal-title":"Science (80- )"},{"issue":"8","key":"10068_CR179","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrn3921","volume":"16","author":"MP Lun","year":"2015","unstructured":"Lun, M. P., Monuki, E. S., & Lehtinen, M. K. (2015). Development and functions of the choroid plexus-cerebrospinal fluid system. Nat Rev Neurosci., 16(8), 445\u2013457. https:\/\/doi.org\/10.1038\/nrn3921.","journal-title":"Nat Rev Neurosci."},{"issue":"146","key":"10068_CR180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2019.00146","volume":"11","author":"GA Edwards III","year":"2019","unstructured":"Edwards III, G. A., Gamez, N., Escobedo Jr., G., Calderon, O., & Moreno-gonzalez, I. (2019). Modifiable Risk Factors for Alzheimer\u2019s Disease. Front Aging Neurosci., 11(146), 1\u201318. https:\/\/doi.org\/10.3389\/fnagi.2019.00146.","journal-title":"Front Aging Neurosci."},{"issue":"19162","key":"10068_CR181","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-55631-8","volume":"9","author":"A Harbuzariu","year":"2019","unstructured":"Harbuzariu, A., Pitts, S., Cespedes, J. C., et al. (2019). Modelling heme-mediated brain injury associated with cerebral malaria in human brain cortical organoids. Sci Rep., 9(19162), 1\u201314. https:\/\/doi.org\/10.1038\/s41598-019-55631-8.","journal-title":"Sci Rep."},{"issue":"9","key":"10068_CR182","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jgg.2017.09.005","volume":"44","author":"W Shang","year":"2017","unstructured":"Shang, W., Wang, F., Fan, G., & Wang, H. (2017). Key elements for designing and performing a CRISPR\/Cas9-based genetic screen. J Genet Genomics., 44(9), 439\u2013449. https:\/\/doi.org\/10.1016\/j.jgg.2017.09.005.","journal-title":"J Genet Genomics."},{"key":"10068_CR183","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1039\/C5LC00180C","volume":"15","author":"EL Moreno","year":"2015","unstructured":"Moreno, E. L., Hachi, S., Hemmer, K., et al. (2015). Differentiation of neuroepithelial stem cells into functional dopaminergic neurons in 3D microfluidic cell culture. Lab Chip., 15, 2419\u20132428. https:\/\/doi.org\/10.1039\/C5LC00180C.","journal-title":"Lab Chip."},{"issue":"40573","key":"10068_CR184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep40573","volume":"7","author":"MM Adil","year":"2017","unstructured":"Adil, M. M., Rodrigues, G. M. C., Kulkarni, R. U., & Rao, A. T. (2017). Efficient generation of hPSC- derived midbrain dopaminergic neurons in a fully defined, scalable, 3D biomaterial platform. Sci Rep., 7(40573), 1\u201311. https:\/\/doi.org\/10.1038\/srep40573.","journal-title":"Sci Rep."},{"key":"10068_CR185","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.stemcr.2017.03.010","volume":"8","author":"AS Monzel","year":"2017","unstructured":"Monzel, A. S., Smits, L. M., Hemmer, K., et al. (2017). Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells. Stem Cell Reports., 8, 1144\u20131154. https:\/\/doi.org\/10.1016\/j.stemcr.2017.03.010.","journal-title":"Stem Cell Reports."},{"key":"10068_CR186","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/nan.12396","volume":"43","author":"M Son","year":"2017","unstructured":"Son, M., Sim, H., Son, Y. S., et al. (2017). Distinctive genomic signature of neural and intestinal organoids from familial Parkinson\u2019 s disease patient- derived induced pluripotent stem cells. Neuropathol Appl Neurobiol., 43, 584\u2013603. https:\/\/doi.org\/10.1111\/nan.12396.","journal-title":"Neuropathol Appl Neurobiol."},{"key":"10068_CR187","doi-asserted-by":"publisher","unstructured":"Jarazo, J., Barmpa, K., Rosety, I., et al. Parkinson\u2019s disease phenotypes in patient specific brain organoids are improved by HP-\u03b2-CD treatment. 2019. https:\/\/doi.org\/10.1101\/813089","DOI":"10.1101\/813089"},{"issue":"3","key":"10068_CR188","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.stemcr.2019.01.020","volume":"12","author":"H Kim","year":"2019","unstructured":"Kim, H., Park, H. J., Choi, H., et al. (2019). Modeling G2019S-LRRK2 Sporadic Parkinson\u2019s Disease in 3D Midbrain Organoids. Stem Cell Reports., 12(3), 518\u2013531. https:\/\/doi.org\/10.1016\/j.stemcr.2019.01.020.","journal-title":"Stem Cell Reports."},{"key":"10068_CR189","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-019-0078-4","volume":"5","author":"LM Smits","year":"2019","unstructured":"Smits, L. M., & Reinhardt, L. (2019). Reinhardt P, et al. Modeling Parkinson\u2019s disease in midbrain-like organoids. npj Park Dis., 5, 1\u20138. https:\/\/doi.org\/10.1038\/s41531-019-0078-4.","journal-title":"Modeling Parkinson\u2019s disease in midbrain-like organoids. npj Park Dis."},{"issue":"694","key":"10068_CR190","first-page":"1","volume":"21","author":"P Chlebanowska","year":"2020","unstructured":"Chlebanowska, P., Tejchman, A., Su\u0142kowski, M., & Skrzypek, K. (2020). Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson\u2019 s Disease. Int J Mol Sci., 21(694), 1\u201313.","journal-title":"Int J Mol Sci."},{"key":"10068_CR191","doi-asserted-by":"publisher","unstructured":"Kwak, T. H., Hali, S., Kim, J., et al. (2020). Generation of homogeneous midbrain organoids with in vivo - like cellular composition facilitates neurotoxin-based Parkinson\u2019 s disease modeling. Stem Cells., 1\u201314. https:\/\/doi.org\/10.1002\/stem.3163.","DOI":"10.1002\/stem.3163"},{"key":"10068_CR192","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.stemcr.2019.08.011","volume":"13","author":"M Nakamura","year":"2019","unstructured":"Nakamura, M., Shiozawa, S., Tsuboi, D., et al. (2019). Pathological Progression Induced by the Frontotemporal Dementia- Associated R406W Tau Mutation in Patient-Derived iPSCs. Stem Cell Reports., 13, 684\u2013699. https:\/\/doi.org\/10.1016\/j.stemcr.2019.08.011.","journal-title":"Stem Cell Reports."},{"key":"10068_CR193","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1007\/s12035-015-9129-y","volume":"53","author":"F Faghihi","year":"2016","unstructured":"Faghihi, F., Mirzaei, E., Ai, J., & Lotfi, A. (2016). Differentiation Potential of Human Chorion-Derived Mesenchymal Stem Cells into Motor Neuron-Like Cells in Two- and Three-Dimensional Culture Systems. Mol Neurobiol., 53, 1862\u20131872. https:\/\/doi.org\/10.1007\/s12035-015-9129-y.","journal-title":"Mol Neurobiol."},{"key":"10068_CR194","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.stemcr.2017.09.021","volume":"9","author":"J Kawada","year":"2017","unstructured":"Kawada, J., Kaneda, S., Kirihara, T., et al. (2017). Generation of a Motor Nerve Organoid with Human Stem Cell-Derived Neurons. Stem Cell Reports., 9, 1441\u20131449. https:\/\/doi.org\/10.1016\/j.stemcr.2017.09.021.","journal-title":"Stem Cell Reports."},{"issue":"eaat5847","key":"10068_CR195","first-page":"1","volume":"4","author":"T Osaki","year":"2018","unstructured":"Osaki, T., Uzel, S. G. M., & Kamm, R. D. (2018). Microphysiological 3D model of amyotrophic lateral sclerosis ( ALS ) from human iPS-derived muscle cells and optogenetic motor neurons. Science Advances, 4(eaat5847), 1\u201315.","journal-title":"Science Advances"},{"key":"10068_CR196","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ebiom.2019.06.013","volume":"45","author":"T Akiyama","year":"2019","unstructured":"Akiyama, T., Suzuki, N., Ishikawa, M., Fujimori, K., Sone, T., & Kawada, J. (2019). Aberrant axon branching via Fos-B dysregulation in FUS -ALS motor neurons. EBioMedicine., 45, 362\u2013378. https:\/\/doi.org\/10.1016\/j.ebiom.2019.06.013.","journal-title":"EBioMedicine."},{"key":"10068_CR197","doi-asserted-by":"publisher","unstructured":"Conforti, P., Besusso, D., Bocchi, V. D., et al. (2017). Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes. PNAS., E762\u2013E771. https:\/\/doi.org\/10.1073\/pnas.1715865115.","DOI":"10.1073\/pnas.1715865115"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-020-10068-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-020-10068-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-020-10068-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T07:02:34Z","timestamp":1744182154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-020-10068-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":197,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10068"],"URL":"https:\/\/doi.org\/10.1007\/s12015-020-10068-9","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]},"assertion":[{"value":"25 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}